Elias A, Pasin C, Smuk M, Paterson A, et al. Outcomes of real-world initiation of long-acting injectable cabotegravir and rilpivirine (LA-I CAB + RPV) in individuals with viraemia: A systematic review of baseline characteristics, virological failure outcomes and discontinuations. HIV Med 2025 Sep 13. doi: 10.1111/hiv.70113.
PMID: 40944511